2020-01-14 Product news
Saskachewan researchers aiming to develop a vaccine for coronavirus outbreak in China
Researchers at the University of Saskatchewan are aiming to develop a vaccine that could help address an outbreak of coronavirus in China.
This article is related to Alfa Laval's stainless steel separation and fluid control equipment. Alfa Laval's Heat Transfer, Separation and Hygienic Fluid Handling products are used by pharmaceutical manufacturers in Canada.
Read the full article on cbc.ca
“…Researchers at the University of Saskatchewan are aiming to develop a vaccine that could help address an outbreak of coronavirus that has killed six people in China.
On Monday, Chinese health officials on the frontline of the outbreak confirmed to state media that human-to-human transmission of the virus has occurred and the number of cases has more than tripled, according to the Associated Press.
The outbreak is believed to have started in a seafood market in the central-Chinese city of Wuhan, but it has since spread to Beijing and Guangdong. Wuhan Mayor Zhou Xianwang told state television that 258 cases had been confirmed in the city, with six deaths.
The outbreak has since spread to Japan, Thailand and South Korea. The virus is linked to the same family of viruses as Severe Acute Respiratory Syndrome (SARS), which killed dozens of Canadians in 2002 and 2003.
…Now, researchers from the University of Saskatchewan's Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac) have requested to work with the virus through the Public Health Agency of Canada's National Microbiology Laboratory in Winnipeg.
…researchers at VIDO-InterVac have extensive experience with coronavirus, as the first vaccine for the virus in cattle was developed at the lab, with research around the virus continuing today…
…they're now looking to develop a vaccine specifically for the virus affecting China, which has come to be known as the Wuhan strain. Since the sequence of the virus was just released last week, they're still in the very early stages of research…”
Read the rest of the article on cbc.ca